Keros Therapeutics
Price & Volume
Stats
See more52W Range | $9.12-$72.37 |
Market Cap | $637.6M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $232.8M |
Revenue Growth (YoY) | 49,002.7% |
Gross Profit (12 Mos) | $219.4M |
Diluted EPS | $0.32 |
News
See moreYahoo Finance • last month
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
Yahoo Finance • 2 months ago
Sector Update: Health Care Stocks Rise Pre-Bell Friday
Yahoo Finance • 2 months ago
Keros Therapeutics' Duchenne Muscular Dystrophy Treatment Gets FDA's Orphan Drug Designation
Yahoo Finance • 2 months ago
Form 8K Keros Therapeutics Inc For: 20 August
About
CEO | Dr. Jasbir S. Seehra Ph.D. |
Address | 1050 Waltham Street, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 148 |
